Full year G and A costs were 9.3% of revenue as compared to 11% in fiscal 2023, representing 170 basis points of leverage and we remain focused on consistently leveraging G and A expenses on an annual basis. Briefly covering our GAAP results. For Q4, gross profit was $240,400,000 operating income was $62,900,000 dollars and net income was $48,800,000 For the full year, gross profit was $960,800,000 operating income was $260,100,000 and net income was $206,800,000 In regard to funds held for clients and interest income, our average daily balance of client funds was $2,800,000,000 in Q4 and $2,600,000,000 for fiscal 2024. We are estimating the average Gilead balance will be approximately $2,500,000,000 in Q1 of fiscal 2025 with an average annual yield of approximately 4.50 basis points, representing approximately $28,000,000 of interest income on client health funds in Q1. On a full year basis, we are estimating the average diluted balance will be $2,750,000,000 in fiscal 2025 with an average yield of approximately 3.90 basis points, representing approximately $107,000,000 of interest income on funds held for clients.